17:59 , Aug 3, 2018 |  BC Week In Review  |  Company News

China Medical gains Chinese product rights in trio of deals

China Medical System Holdings Ltd. (HKSE:867) announced a series of deals in July under which it gained rights to several products in China, including Hong Kong, Macao and Taiwan. China Medical obtained exclusive rights from Venus...
23:02 , Dec 22, 2017 |  BC Extra  |  Company News

Management tracks: CRISPR, Hua

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) appointed Rodger Novak as chairman of the board. He succeeds Tony Coles, who will remain as a senior adviser. Novak is founder and president of CRISPR, and served...
20:17 , Feb 16, 2017 |  BC Week In Review  |  Financial News

Acticor completes venture financing

Acute ischemic stroke company Acticor Biotech S.A.S. (Paris, France) raised €1.5 million ($1.6 million) from CapDecisif in the second close of a venture round on Feb. 7, bringing the total raised to €2.9 million ($3.2...
21:32 , Nov 18, 2016 |  BC Week In Review  |  Company News

Acticor, Mediolanum deal

Acticor and Mediolanum partnered to develop Acticor’s acute ischemic stroke candidate ACT017. Mediolanum will co-own the results of the collaboration and acquire marketing rights in two undisclosed European countries. Acticor received an undisclosed upfront payment...
07:00 , Jul 18, 2016 |  BC Week In Review  |  Financial News

Acticor Biotech completes venture financing

Acticor Biotech, Paris, France   Business: Antibodies, Neurology   Date completed: 2016-07-11   Type: Venture financing   Raised: EUR670,000 ($738,742)   Investors: ARMESA; angel investors   Note: Acticor also raised an additional EUR740,000 ($815,924) in the round from crowdfunding.   ...